ct.\*:(%22Vaccines%2C antisera%2C therapeutical immunoglobulins and monoclonal antibodies%22)
Results 1 to 25 of 33982
Selection :
Quelle pharmacovigilance pour les vaccins ? = Which pharmacovigilance for vaccines?LE LOUËT, Hervé; LOUPI, Elisabeth; HARAMBURU, Francoise et al.Thérapie (Paris). 2007, Vol 62, Num 3, pp 241-247, issn 0040-5957, 7 p.Conference Paper
The comparative study of the safety of a vaccinal process in both oral and epicutaneous immunization against smallpoxBEKTIMIROV, T. A; PODKUIKO, V. N; GRIGORYEVA, L. V et al.Voprosy virusologii. 2002, Vol 47, Num 4, pp 9-13, issn 0507-4088, 5 p.Article
A mathematical model describing the thermal virus inactivationNOËL, Catherine; CHARLES, Sandrine; FRANCON, Alain et al.Vaccine. 2001, Vol 19, Num 25-26, pp 3575-3582, issn 0264-410XArticle
Analysis of the ontogeny of the murine humoral response to Neisseria meningitidis B capsular polysaccharide reveals levels of complexity relevant to vaccine developmentCOLINO, Jesus; OUTSCHOORN, Ingrid.The Journal of infectious diseases. 2001, Vol 184, Num 12, pp 1538-1547, issn 0022-1899Article
Antibodies to BrKA augment killing of Bordetella pertussisOLIVER, David C; FERNANDEZ, Rachel C.Vaccine. 2001, Vol 20, Num 1-2, pp 235-241, issn 0264-410XArticle
Characterization of a human H9N2 influenza virus isolated in Hong KongSAITO, Takehiko; LIMB, Wilina; SUZUKI, Takashi et al.Vaccine. 2001, Vol 20, Num 1-2, pp 125-133, issn 0264-410XArticle
CpG containing oligodeoxynucleotides are potent adjuvants for parenteral vaccination with the fusion (F) protein of respiratory syncytial virus (RSV)HANCOCK, Gerald E; HEERS, Kristen M; SMITH, Jason D et al.Vaccine. 2001, Vol 19, Num 32, pp 4874-4882, issn 0264-410XArticle
Diphtheria antitoxin levels among children primed with a diphtheria and tetanus toxoids and acellular pertussis vaccine lot with a subpotent diphtheria toxoid componentJACKSON, Lisa A; FALLS, Sherry; ONCHEE YU et al.The Journal of infectious diseases. 2001, Vol 183, Num 11, pp 1698-1700, issn 0022-1899Article
Immune responses in goats to recombinant hemagglutinin-neuraminidase glycoprotein of Peste des petits ruminants virus: identification of a T cell determinantSINNATHAMBY, G; RENUKARADHYA, G. J; RAJASEKHAR, M et al.Vaccine. 2001, Vol 19, Num 32, pp 4816-4823, issn 0264-410XArticle
Immunization of mice with lipopeptide antigens encapsulated in novel liposomes prepared from the polar lipids of various Archaeobacteria elicits rapid and prolonged specific protective immunity against infection with the facultative intracellular pathogen, Listeria monocytogenesCONLAN, J. Wayne; KRISHNAN, Lakshmi; WILLICK, Gordon E et al.Vaccine. 2001, Vol 19, Num 25-26, pp 3509-3517, issn 0264-410XArticle
Influenza vaccine effectiveness in preventing hospitalizations and deaths in persons 65 years or older in Minnesota, New York, and Oregon : Data from 3 health plansNORDIN, James; MULLOOLY, John; POBLETE, Sung et al.The Journal of infectious diseases. 2001, Vol 184, Num 6, pp 665-670, issn 0022-1899Article
Marburg virus vaccines : comparing classical and new approachesHEVEY, M; NEGLEY, D; VANDERZANDEN, L et al.Vaccine. 2001, Vol 20, Num 3-4, pp 586-593, issn 0264-410XArticle
Onset and duration of protective immunity to IA/IB and IE strains of Venezuelan equine encephalitis virus in vaccinated miceHART, Mary Kate; LIND, Cathleen; BAKKEN, Russell et al.Vaccine. 2001, Vol 20, Num 3-4, pp 616-622, issn 0264-410XArticle
Serum samples from infants vaccinated with a pneumococcal conjugate vaccine, PncT, protect mice against invasive infection caused by streptococcus pneumoniae serotypes 6A and 6BSAELAND, Eirikur; JAKOBSEN, Havard; INGOLFSDOTTIR, Gunnhildur et al.The Journal of infectious diseases. 2001, Vol 183, Num 2, pp 253-260, issn 0022-1899Article
A purified inactivated Japanese encephalitis virus vaccine made in vero cellsSRIVASTAVA, Ashok K; PUTNAK, J. Robert; TOWLE, Andrew C et al.Vaccine. 2001, Vol 19, Num 31, pp 4557-4565, issn 0264-410XConference Paper
Rationnel et évolution du calendrier vaccinal en France = Rationale and evolution of the French immunisation programmeDENIS, Francois.Thérapie (Paris). 2005, Vol 60, Num 3, pp 215-220, issn 0040-5957, 6 p.Conference Paper
Construction of a tetR-integrated Salmonella enterica serovar typhi CVD908 strain that tightly controls expression of the major merozoite surface protein of Plasmodium falciparum for applications in human vaccine productionFENG QIAN; WEIQING PAN.Infection and immunity. 2002, Vol 70, Num 4, pp 2029-2038, issn 0019-9567Article
Lipopeptide stimulation of MHC class I-restricted memory cytotoxic T lymphocytes from equine infectious anemia virus-infected horsesRIDGELY, Sherritta L; MCGUIRE, Travis C.Vaccine. 2002, Vol 20, Num 13-14, pp 1809-1819, issn 0264-410XArticle
Mucosal immunity in mice immunized with HIV-1 peptide conjugated to Brucella abortusGOLDING, Basil; ELLER, Nancy; LEVY, Lily et al.Vaccine. 2002, Vol 20, Num 9-10, pp 1445-1450, issn 0264-410XArticle
New approach for generation of neutralizing antibody against human T-cell leukaemia virus type-I (HTLV-I) using phage clonesBEGUM, Nurjahan; HORIUCHI, Sankichi; TANAKA, Yuetsu et al.Vaccine. 2002, Vol 20, Num 9-10, pp 1281-1289, issn 0264-410XArticle
Protective immune responses to the 42-kilodalton (kDa) region of Plasmodium yoelii merozoite surface protein 1 are induced by the C-terminal 19-kDa region but not by the adjacent 33-kDa regionAHLBORG, Niklas; LING, Irene T; HOWARD, Wendy et al.Infection and immunity. 2002, Vol 70, Num 2, pp 820-825, issn 0019-9567Article
Reduction of animal use in human vaccine quality control: opportunities and problemsMETZ, Bernard; HENDRIKSEN, Coenraad. F. M; JISKOOT, Wim et al.Vaccine. 2002, Vol 20, Num 19-20, pp 2411-2430, issn 0264-410XArticle
Remarkably high antibody levels and protection against P. falciparum malaria in Aotus monkeys after a single immunisation of SPf66 encapsulated in PLGA microspheresROSAS, J. E; PEDRAZ, J. L; HERNANDEZ, R. M et al.Vaccine. 2002, Vol 20, Num 13-14, pp 1707-1710, issn 0264-410XArticle
An outbreak of typhoid fever, xing-an county, People's Republic of China, 1999 : Estimation of the field effectiveness of Vi polysaccharide typhoid vaccineHONG HUI YANG; KILGORE, Paul E; LING HONG YANG et al.The Journal of infectious diseases. 2001, Vol 183, Num 12, pp 1775-1780, issn 0022-1899Article
Immunization with A2 protein results in a mixed Thl/Th2 and a humoral response which protects mice against Leishmania donovani infectionsGHOSH, Anirban; WEN WEI ZHANG; MATLASHEWSKI, Greg et al.Vaccine. 2001, Vol 20, Num 1-2, pp 59-66, issn 0264-410XArticle